Skip to main content
Fig. 2 | Trials

Fig. 2

From: CompLement C5 Antibodies for decreasing brain injury after aneurysmal Subarachnoid Haemorrhage (CLASH): study protocol for a randomised controlled phase II clinical trial

Fig. 2

Study procedures. CSF, cerebrospinal fluid; GCS, Glasgow Coma Score; WFNS, World Federation of Neurosurgical Societies; NIHSS, National Institutes of Health Stroke Scale; MRI, magnetic resonance imaging; AEs, adverse events; SAEs, serious adverse events; MoCA, Montreal Cognitive Assessment; EQ-5D-5L, standardized instrument for use as a measure of health outcome

Back to article page

Trials

ISSN: 1745-6215